The G2019S LRRK2 mutation is rare in Korean patients with Parkinson's disease

被引:21
|
作者
Cho, Jin-Whan
Kim, Sung-Yeon
Park, Sung-Sup
Kim, Han-Jun
Ahn, Tae-Beom
Kim, Jong-Min
Jeon, Beom-Seok
机构
[1] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul 110744, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul 110744, South Korea
[3] Seoul Natl Univ, Coll Med, MRC, Seoul 110744, South Korea
[4] Kyung Hee Univ, Seoul, South Korea
[5] Boramae City Hosp, Seoul, South Korea
[6] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[7] Bundang Hosp, Seoul, South Korea
关键词
D O I
10.1017/S0317167100005783
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: A number of causative mutations such as a-synuclein, parkin, UCHL1, Pink-1, DJ-1 have been identified in Parkinson's disease (PD). They are usually found in the familial cases. One mutation of great interest is the G2019S mutation in the LRRK2 gene, which has been reported in both familial and sporadic PD. Its prevalence has been reported to vary markedly among different races. We examined the prevalence of the G2019S mutation in the Korean PD population for genetic study planning. Methods: We conducted a genetic analysis of the 620195 mutation by standard PCR and restriction digestion method. 453 PD patients were studied, 34% of whom had an age at onset of < 50 years and 3.8% had a positive family history. Results: None of the 453 study subjects carried the G2019S mutation. Conclusions: Our result confirms previous reports that the G2019S mutation is rare among PD patients in the Asian population. This result supports the notion that the prevalence of this LRRK2 mutation is population specific, and that there may be a founder effect within western populations.
引用
下载
收藏
页码:53 / 55
页数:3
相关论文
共 50 条
  • [21] G2019S LRRK2 mutation in familial and sporadic Parkinson's disease in Russia
    Pchelina, Sofya N.
    Yakimovskii, Andrei F.
    Ivanova, Olga N.
    Emelianov, Anton K.
    Zakharchuk, Andrei H.
    Schwarzman, Alexander L.
    MOVEMENT DISORDERS, 2006, 21 (12) : 2234 - 2236
  • [22] The LRRK2 G2019S mutation as the cause of Parkinson’s disease in Ashkenazi Jews
    Avner Thaler
    Elissa Ash
    Ziv Gan-Or
    Avi Orr-Urtreger
    Nir Giladi
    Journal of Neural Transmission, 2009, 116 : 1473 - 1482
  • [23] The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease:: Phenotype in monozygotic twins
    Munhoz, Renato P.
    Wakutani, Yosuke
    Marras, Connie
    Teive, Helio A.
    Raskin, Salmo
    Werneck, Lineu C.
    Moreno, Danielle
    Sato, Christine
    Lang, Anthony E.
    Rogaeva, Ekaterina
    MOVEMENT DISORDERS, 2008, 23 (02) : 290 - 294
  • [24] Subthalamic nucleus stimulation in patients with Parkinson's disease due to the LRRK2 G2019S mutation
    Hassin-Baer, S.
    Cohen, O. S.
    Balash, Y.
    Israel, Z.
    Fried, I.
    Strauss, H.
    Hillel, A.
    Giladi, N.
    Friedman, E.
    Orr-Urtreger, A.
    Gurevich, T.
    MOVEMENT DISORDERS, 2009, 24 : S466 - S466
  • [25] The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease
    Kalinderi, K.
    Fidani, L.
    Bostantjopoulou, S.
    Katsarou, Z.
    Kotsis, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (10) : 1088 - 1090
  • [26] Leukocyte MAPK activity associated with the LRRK2 G2019S mutation and Parkinson's disease
    Aasly, Jan O.
    Toft, Mathias
    Kvam, Sylvia N.
    Farrer, Matthew J.
    White, Linda R.
    ANNALS OF NEUROLOGY, 2006, 60 : S9 - S9
  • [27] Fall Risk and Gait in Parkinson's Disease: The Role of the LRRK2 G2019S Mutation
    Mirelman, Anat
    Heman, Talia
    Yasinovsky, Kira
    Thaler, Avner
    Gurevich, Tanya
    Marder, Karen
    Bressman, Susan
    Bar-Shira, Anat
    Orr-Urtreger, Avi
    Giladi, Nir
    Hausdorff, Jeffrey M.
    MOVEMENT DISORDERS, 2013, 28 (12) : 1683 - 1690
  • [28] Escaping Parkinson's disease:: A neurologically healthy octogenarian with the LRRK2 G2019S mutation
    Kay, DM
    Kramer, P
    Higgins, D
    Zabetian, CP
    Payami, H
    MOVEMENT DISORDERS, 2005, 20 (08) : 1077 - 1078
  • [29] Analysis of the LRRK2 G2019S mutation in Alzheimer disease
    Zabetian, CP
    Lauricella, CJ
    Tsuang, DW
    Leverenz, JB
    Schellenberg, GD
    Payami, H
    ARCHIVES OF NEUROLOGY, 2006, 63 (01) : 156 - 157
  • [30] DEEP PHENOTYPING OF THE G2019S LRRK2 MUTATION IN PARKINSON'S DISEASE: UCL COHORT
    Rizig, Mie
    Jonvik, Hallgeir
    Foltynie, Thomas
    Limousin, Patricia
    Bhatia, Kailash
    Warner, Thomas
    Morris, Huw
    Wood, Nicholas
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (12):